Prognostic value of S-Phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis

Modern Pathology

Volumn 10, Issue 3, 1997, Pages 216-222

  Peiro G ^a   Lerma, E ^a,b   Climent, M A ^a   Segui M A ^a   Alonso, M C ^a   Prat, J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Breast cancer; DNA; Flow cytometry; Image analysis; Pathology; Prognostic factors; S phase fraction

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CELL CYCLE S PHASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; IMAGE CYTOMETRY; MIDDLE AGED; MITOTIC INDEX; PLOIDIES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; S PHASE; SURVIVAL ANALYSIS;

EID: 0030895444     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Clark GM, Wenger CR, Beardslee S, Owens MA, Pounds G, Olkader T, et al. How to integrate steroid hormone receptor, flow cytometry, and other prognostic information in regard to primary breast cancer. Cancer 1993;71:2157-62.
2. Clark GM, Mathieu MC, Owens MA, Dressier LG, Endey L, Tormey DC, et al. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol 1992;10:428-32.
3. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
4. Frierson HF. Grade, flow cytometric analysis of ploidy for infiltrating ductal carcinomas. Hum Pathol 1993;24:24-9.
5. Johnson H, Masood S, Belluco C. Prognostic factors in node-negative breast cancer. Arch Surg 1992;127:1386-91.
6. Keshgegian AA, Cnaan A. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. Am J Clin Pathol 1995;104:42-9.
7. McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS, Bauer WC. A proposed classification of breast cancer based on kinetic information. Cancer 1986;57:269-76.
8. McGuire WL, Clark GM. Prognostic factors and treatment decisions in axillary node-negative breast cancer. N Engl J Med 1992;326:1756-61.
9. Merkel DE, Winchester DJ, Goldschmidt RA, August CZ, Wruck DM, Rademaker AW. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer. Cancer 1993;72:1926-32.
10. Mink D, von Tongelen B, Villena-Heisen C, Heiss C, Schmidt W. Breast cancer and prognostic factors. Tumor size, degree of differentiation, proliferation kinetics and expression of steroid receptors. Eur J Gynaecol Oncol 1994;15:424-36.
11. Muss HB, Kute TE, Case LD, Smith LR, Booher C, Long R, et al. The relation of flow cytometry to clinical and biologic characteristics in women with node-negative primary breast cancer. Cancer 1989;64:1894-1900.
12. O'Leary TJ, Hayashi T, Cunningham R, Griffin J, Norris HJ. Long-term outcome in node-negative breast cancer: prognostic factors [abstract]. Mod Pathol 1995;8:23A.
13. O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Rubens RD, Richards MA. Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol 1990;8:2040-6.
14. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Ferno M, Killander D, et al. Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990;322:1045-53.
15. Siitonen SM, Kallioniemi O, Helin HJ, Isola JJ. Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections. Hum Pathol 1993;24:1348-53.
16. Uyterlinde AN, Schipper NW, Baak JPA, Peterse H, Matze E. Limited prognosis value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer. Am J Clin Pathol 1988;89:301-7.
17. Witzig TE, Gonchoroff NJ, Therneau T, Gilberston DT, Wold LE, Grant C, et al. DNA content flow cytometry as a prognostic factor for node-positive breast cancer. Cancer 1991; 68:1781-8.
18. Babiak J, Hugh J, Poppema S. Significance of c-erb-B2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer. Cancer 1992;70:770-6.
19. Bacus SS, Chin DM, Stern RK, Ortiz R, Ruby SG, Weinberg DS. HER-2/neu oncogene expression, DNA ploidy and proliferation index in breast cancer. Anal Quant Cytol Histol 1992;14:433-45.
20. Gasparini G, Gullick WJ, Bevilacqua P, Sainsbury JR, Meli S, Boracchi P, et al. Human breast cancer: prognostic significance of the c-erb-B2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy and conventional pathologic features. J Clin Oncol 1992;10:686-95.
21. Lee AK, Wiley B, Loda M, Bosari S, Dugan JM, Hamilton W, et al. DNA ploidy, proliferation and neu-oncogene protein overexpression in breast carcinoma. Mod Pathol 1992;5:61-7.
22. Schimmelpenning H, Erikson ET, Franzen B, Zetterberg A, Auer GU. Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive human mammary carcinomas. Virchows Arch A Pathol Anat Histopathol 1993;423: 273-9.
23. Visscher DW, Sarkar FH, Crissman JD. Correlation of DNA ploidy with c-erb-B2 expression in preinvasive and invasive breast tumors. Anal Quant Cytol Hist 1991;13:418-24.
24. Arnerlov C, Emdin SO, Lundgren B, Roos G, Soderstrom J, Bjersing L, et al. Mammographic growth rate, DNA ploidy and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population. Cancer 1992;70: 1935-42.
25. Arnerlov C, Emdin SO, Lundgren B, Roos G, Soderstrom J, Bjersing L, et al. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population. Cancer 1992;70:1928-34.
26. Batsakis JG, Sneige N, El-Naggar AK. Flow cytometric (DNA content and S-phase fraction; analysis of breast cancer. Cancer 1993;71:2151-3.
27. Clark GM, Dressier LG, Owens MA, Pounds G, Oldaker T, McGuire WL. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 1989;320:627-33.
28. Dressier LG, Seamer LC, Owens MA, Clark GM, McGuire WL. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988;61:420-7.
29. Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, et al. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Cancer 1991; 68:1465-75.
30. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 1993;14: 482-5.
31. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, et al. Improving, the prognostic value of DNA flow cytometry in breast cancer by combining DNA histograms in breast cancer. Cancer 1988;62:2183-90.
32. Keyhani-Rofagha S, O'Toole RV, Farrar WB, Sickle-Santanello B, DeCenzo J, Young D. Is DNA ploidy an independent prognostic factor in infiltrative node-negative breast adeno-carcinoma? Cancer 1990;65:1577-82.
33. Olszewzki W, Darzynkiewick Z, Rosen PP, Schwartz MK, Melamed MR. Flow cytometry of breast carcinoma. I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer 1981;48:980-4.
34. Toikkanen S, Joensuu H, Klemi P. Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer. Am J Clin Pathol 1990;93:471-9.
35. Bauer TW, Tubbs RR, Edinger MG, Suit PF, Gephardt GN, Levin HS. A prospective comparison of DNA quantitation by image and flow cytometry. Am J Clin Pathol 1990;93:322-6.
36. Bosari S, Wiley BD, Hamilton WM, Dugan JM, Cook LB, Lee AKC. DNA measurement by image analysis of paraffin-embedded breast carcinoma tissue. A comparative investigation. Am J Clin Pathol 1991;96:698-703.
37. Claud RD, Weinstein RS, Howeedy A, Straus AK, Coon J. Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid tumors. Mod Pathol 1989; 2:463-7.
38. Cornelisse CJ, van Driel-Kulker AM. DNA image cytometry on machine-selected breast cancer cells and comparison between flow cytometry and scanning cytophotometry. Cytometry 1985;6:471-7.
39. Danque POV, Chen HB, Patil J, Jajirdar J, Orsati G, Paronetto F. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol 1993;6:270-5.
40. Kennedy JC, El-Badawy N, DeRose PB, Cohen C. Comparison of cell proliferation in breast carcinoma using image analysis (Ki-67) and flow cytometric systems. Anal Quant Cytol Histol 1992;14:304-11.
41. Lee AKC, Dugan J, Hamilton WM, Cook L, Heatley G, Kamat B, et al. Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry. Mod Pathol 1991;4:178-82.
42. Lee AKC, Wiley B, Dugan J, Hamilton WH, Loda M, Heatley GJ, et al. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry. Pathol Res Pract 1992;188:428-32.
43. Wilbur DC, Zakowski MF, Kosciol CM, Sojda DF, Pastuszak WT. DNA ploidy in breast lesions. A comparative study using two commercial analysis systems and flow cytometry. Anal Quant Cytol Histol 1990;12:28-33.
44. Camplejohn RS, Ash CM, Gillet CE, Raikundalia B, Barnes DM, Gregory WM, et al. The prognosis significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre. Br J Cancer 1995;71:140-5.
45. Lerma E, Oliva E, Tugues D, Prat J. Stromal tumours of the gastrointestinal tract. A clinicopathological and ploidy analysis of 33 cases. Virchows Arch 1994;424:19-24.
46. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
47. Dawson AE, Norton JA, Weinberg DS. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 1990;136: 1115-24.
48. Fallenius AG, Auer GU, Carstensen JM. Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer 1988;62:331-41.
49. Elsheikh TM, Silverman JF, McCool JW, Riley RS. Comparalive DNA analysis of solid tumors by flow cytometric and image analysis of touch imprints and flow cell suspensions. Am J Clin Pathol 1992;98:296-304.
50. Falkner UG, Hagmar T, Auer G. Efficacy of combined image and flow cytometric DNA assessments in human breast cancer: a methodological study based on a routine histopathological material of 2024 excised tumor specimens. Anal Cell Pathol 1990;2:297-312.
51. Ghali VS, Liau S, Teplitz T, Prudente R. A comparative study of DNA ploidy in 115 fresh-frozen breast carcinomas by image analysis vs flow cytometry. Cancer 1992;70:2668-72.
52. Lajoie G, Zbieranowski I, Demianiuk C, Knape WA, Edinger MG, Tubbs RR, et al. A comparative study of DNA quantitation in breast carcinoma with image analysis and in vitro fine-needle aspiration with flow cytometric analysis. Am J Clin Pathol 1993;100:456-62.
53. Eliasen CA, Opitz LM, Vamvakas EC, Espiritu EC, Marsh ER, Roses DF, et al. Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection. Mod Pathol 1991;4:196-200.